Compare · BIS vs DWEQ
BIS vs DWEQ
Side-by-side comparison of ProShares UltraShort Nasdaq Biotechnology (BIS) and AdvisorShares Dorsey Wright Alpha Equal Weight ETF (DWEQ): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BIS and DWEQ operate in n/a (n/a), so they compete in similar markets.
ProShares UltraShort Nasdaq Biotechnology
The investment seeks daily investment results that correspond to two times the inverse (-2x) of the daily performance of the Nasdaq Biotechnology Index®. The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is a modified capitalization weighted index that includes securities of Nasdaq listed companies that are classified as either biotechnology or pharmaceutical. The fund is non-diversified.
AdvisorShares Dorsey Wright Alpha Equal Weight ETF
The investment seeks to provide long-term capital appreciation. The fund is an actively managed exchange-traded fund ("ETF") that seeks to achieve its investment objective by investing in a concentrated portfolio of U.S. equity securities selected from a universe of the largest 1,000 U.S. equity securities based on market capitalization. It's investment focus follows a core philosophy of relative strength. The fund also may invest in repurchase agreements.
Latest BIS
Latest DWEQ
No recent items for AdvisorShares Dorsey Wright Alpha Equal Weight ETF.